From: Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis
Age | Low risk | Medium risk | High risk | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | High BP | Controlled BP | High BP | Controlled BP | High BP | Controlled BP | ||||||
 | CHD | Stroke | CHD | Stroke | CHD | Stroke | CHD | Stroke | CHD | Stroke | CHD | Stroke |
40 | 0.0010 | 0.0041 | 0.0010 | 0.0030 | 0.0041 | 0.0105 | 0.0030 | 0.0051 | 0.0072 | 0.0221 | 0.0041 | 0.0094 |
45 | 0.0020 | 0.0062 | 0.0010 | 0.0041 | 0.0051 | 0.0150 | 0.0041 | 0.0072 | 0.0094 | 0.0323 | 0.0062 | 0.0127 |
50 | 0.0030 | 0.0094 | 0.0020 | 0.0051 | 0.0072 | 0.0221 | 0.0051 | 0.0105 | 0.0138 | 0.0467 | 0.0083 | 0.0185 |
55 | 0.0041 | 0.0138 | 0.0030 | 0.0083 | 0.0105 | 0.0310 | 0.0072 | 0.0150 | 0.0185 | 0.0670 | 0.0116 | 0.0271 |
60 | 0.0051 | 0.0196 | 0.0041 | 0.0116 | 0.0150 | 0.0452 | 0.0105 | 0.0221 | 0.0271 | 0.0946 | 0.0161 | 0.0393 |
65 | 0.0072 | 0.0284 | 0.0062 | 0.0161 | 0.0209 | 0.0651 | 0.0150 | 0.0323 | 0.0378 | 0.1330 | 0.0233 | 0.0563 |
70 | 0.0105 | 0.0407 | 0.0083 | 0.0233 | 0.0297 | 0.0922 | 0.0209 | 0.0452 | 0.0530 | 0.1846 | 0.0323 | 0.0809 |